Which has stronger earnings and valuation, GH or PACS?

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 20.76 -$416.28M -$3.39 N/A PACS Group $5.29B 1.20 $191.54M $1.56 25.60

Does the media prefer GH or PACS?

In the previous week, PACS Group had 6 more articles in the media than Guardant Health. MarketBeat recorded 18 mentions for PACS Group and 12 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.52 beat PACS Group's score of 0.08 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 1 Very Positive mention(s) 5 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PACS or BTSG?

In the previous week, PACS Group had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 18 mentions for PACS Group and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.43 beat PACS Group's score of 0.08 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral BrightSpring Health Services 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor PACS or FMS?

In the previous week, PACS Group had 16 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 18 mentions for PACS Group and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.07 beat PACS Group's score of 0.08 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, HIMS or PACS?

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.37B 3.26 $128.37M -$0.09 N/A PACS Group $5.29B 1.20 $191.54M $1.56 25.60

Does the media favor HIMS or PACS?

In the previous week, PACS Group had 2 more articles in the media than Hims & Hers Health. MarketBeat recorded 18 mentions for PACS Group and 16 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.64 beat PACS Group's score of 0.08 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 6 Very Positive mention(s) 7 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

PACS Group (PACS) Competitors

$39.94 -1.95 (-4.66%)

Closing price 03:59 PM Eastern

Extended Trading

$40.94 +1.01 (+2.52%)

As of 08:00 PM Eastern

Compare

PACS vs. GH, BTSG, FMS, HIMS, and CAI

Should you buy PACS Group stock or one of its competitors? MarketBeat compares PACS Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with PACS Group include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does PACS Group compare to Guardant Health?

Guardant Health (NASDAQ:GH) and PACS Group (NYSE:PACS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

Guardant Health currently has a consensus price target of $144.82, suggesting a potential downside of 5.80%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 20.19%. Given PACS Group's higher possible upside, analysts plainly believe PACS Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	3.00
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, PACS Group had 6 more articles in the media than Guardant Health. MarketBeat recorded 18 mentions for PACS Group and 12 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.52 beat PACS Group's score of 0.08 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	1 Very Positive mention(s)	5 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	20.76	-$416.28M	-$3.39	N/A
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.60

PACS Group has a net margin of 4.49% compared to Guardant Health's net margin of -40.10%. PACS Group's return on equity of 26.47% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
PACS Group	4.49%	26.47%	4.36%

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

PACS Group beats Guardant Health on 10 of the 16 factors compared between the two stocks.

How does PACS Group compare to BrightSpring Health Services?

PACS Group (NYSE:PACS) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations.

PACS Group has higher earnings, but lower revenue than BrightSpring Health Services. PACS Group is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.60
BrightSpring Health Services	$12.91B	1.05	$190.67M	$1.41	48.92

PACS Group has a net margin of 4.49% compared to BrightSpring Health Services' net margin of 2.27%. PACS Group's return on equity of 26.47% beat BrightSpring Health Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
BrightSpring Health Services	2.27%	14.63%	4.41%

PACS Group presently has a consensus price target of $48.00, indicating a potential upside of 20.19%. BrightSpring Health Services has a consensus price target of $61.27, indicating a potential downside of 11.18%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11

In the previous week, PACS Group had 16 more articles in the media than BrightSpring Health Services. MarketBeat recorded 18 mentions for PACS Group and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.43 beat PACS Group's score of 0.08 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

PACS Group and BrightSpring Health Services tied by winning 7 of the 14 factors compared between the two stocks.

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

PACS Group (NYSE:PACS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, PACS Group had 16 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 18 mentions for PACS Group and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.07 beat PACS Group's score of 0.08 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PACS Group currently has a consensus target price of $48.00, indicating a potential upside of 20.19%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 23.09%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than PACS Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.60
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.55	$1.11B	$1.90	11.97

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Summary

PACS Group beats Fresenius Medical Care AG & Co. KGaA on 8 of the 15 factors compared between the two stocks.

How does PACS Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

In the previous week, PACS Group had 2 more articles in the media than Hims & Hers Health. MarketBeat recorded 18 mentions for PACS Group and 16 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.64 beat PACS Group's score of 0.08 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	6 Very Positive mention(s)	7 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	4 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.37B	3.26	$128.37M	-$0.09	N/A
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.60

PACS Group has a net margin of 4.49% compared to Hims & Hers Health's net margin of -0.56%. PACS Group's return on equity of 26.47% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
PACS Group	4.49%	26.47%	4.36%

Hims & Hers Health currently has a consensus price target of $29.37, indicating a potential downside of 11.96%. PACS Group has a consensus price target of $48.00, indicating a potential upside of 20.19%. Given PACS Group's stronger consensus rating and higher probable upside, analysts clearly believe PACS Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

PACS Group beats Hims & Hers Health on 12 of the 15 factors compared between the two stocks.

How does PACS Group compare to Caris Life Sciences?

PACS Group (NYSE:PACS) and Caris Life Sciences (NASDAQ:CAI) are both mid-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment and earnings.

PACS Group has a net margin of 4.49% compared to Caris Life Sciences' net margin of 3.75%. Caris Life Sciences' return on equity of 98.28% beat PACS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.49%	26.47%	4.36%
Caris Life Sciences	3.75%	98.28%	48.87%

In the previous week, PACS Group had 17 more articles in the media than Caris Life Sciences. MarketBeat recorded 18 mentions for PACS Group and 1 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 1.89 beat PACS Group's score of 0.08 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
PACS Group	Neutral
Caris Life Sciences	Very Positive

PACS Group has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.60
Caris Life Sciences	$812.03M	6.38	-$68.09M	-$7.61	N/A

PACS Group currently has a consensus target price of $48.00, indicating a potential upside of 20.19%. Caris Life Sciences has a consensus target price of $27.56, indicating a potential upside of 50.41%. Given Caris Life Sciences' higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

Summary

PACS Group beats Caris Life Sciences on 7 of the 13 factors compared between the two stocks.

Get PACS Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PACS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PACS vs. The Competition

Export

Metric	PACS Group	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$6.63B	$9.40B	$6.85B	$23.32B
Dividend Yield	N/A	1.66%	2.66%	4.07%
P/E Ratio	25.60	25.95	26.04	31.73
Price / Sales	1.20	17.07	550.39	21.11
Price / Cash	26.20	14.92	29.09	18.60
Price / Book	6.57	5.99	10.98	4.78
Net Income	$191.54M	$179.69M	$3.57B	$1.07B
7 Day Performance	5.68%	5.72%	3.06%	1.42%
1 Month Performance	9.05%	4.93%	0.72%	0.76%
1 Year Performance	207.07%	16.42%	36.82%	25.45%

PACS Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PACS PACS Group	3.7535 of 5 stars	$39.94 -4.7%	$48.00 +20.2%	+221.3%	$6.63B	$5.29B	25.60	47,455	News Coverage Insider Trade
GH Guardant Health	1.902 of 5 stars	$134.36 +4.3%	$141.95 +5.7%	+193.4%	$17.81B	$982.02M	N/A	2,506	Analyst Forecast
BTSG BrightSpring Health Services	3.3454 of 5 stars	$67.60 +0.6%	$61.27 -9.4%	+193.0%	$13.34B	$12.91B	47.96	23,500	Positive News
FMS Fresenius Medical Care AG & Co. KGaA	4.6462 of 5 stars	$23.69 +1.3%	$28.00 +18.2%	-17.7%	$12.79B	$19.36B	12.47	1,488
HIMS Hims & Hers Health	2.495 of 5 stars	$33.85 +0.9%	$29.37 -13.3%	-31.5%	$7.83B	$2.35B	N/A	2,442

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PACS) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PACS Group (PACS) Competitors

PACS vs. GH, BTSG, FMS, HIMS, and CAI

How does PACS Group compare to Guardant Health?

Summary

How does PACS Group compare to BrightSpring Health Services?

Summary

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does PACS Group compare to Hims & Hers Health?

Summary

How does PACS Group compare to Caris Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PACS vs. The Competition

PACS Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PACS Group (PACS) Competitors

PACS vs. GH, BTSG, FMS, HIMS, and CAI

How does PACS Group compare to Guardant Health?

Do analysts recommend GH or PACS?

Does the media prefer GH or PACS?

Which has stronger earnings and valuation, GH or PACS?

Is GH or PACS more profitable?

Do institutionals and insiders have more ownership in GH or PACS?

Summary

How does PACS Group compare to BrightSpring Health Services?

Which has stronger earnings and valuation, PACS or BTSG?

Is PACS or BTSG more profitable?

Do analysts rate PACS or BTSG?

Does the media prefer PACS or BTSG?

Summary

How does PACS Group compare to Fresenius Medical Care AG & Co. KGaA?

Do insiders and institutionals have more ownership in PACS or FMS?

Does the media favor PACS or FMS?

Do analysts prefer PACS or FMS?

Which has better valuation & earnings, PACS or FMS?

Is PACS or FMS more profitable?

Summary

How does PACS Group compare to Hims & Hers Health?

Does the media favor HIMS or PACS?

Which has stronger valuation and earnings, HIMS or PACS?

Is HIMS or PACS more profitable?

Do analysts prefer HIMS or PACS?

Do insiders & institutionals hold more shares of HIMS or PACS?

Summary

How does PACS Group compare to Caris Life Sciences?

Is PACS or CAI more profitable?

Does the media prefer PACS or CAI?

Which has preferable valuation and earnings, PACS or CAI?

Do analysts prefer PACS or CAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PACS vs. The Competition

PACS Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools